Searched for
DOMESTIC PATENT SHARE
Entrepreneurship and innovation: Scaling India's strategic technology ecosystemIndia's pursuit of technological self-reliance is gathering pace as sovereign capabilities in defence, space, semiconductors, and secure co...- China begins to snap at America's heels in a tightening tech raceChina’s latest supercomputer ranking has renewed debate over global technology leadership, but current evidence shows the United States sti...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Free trade pacts to boost furniture exports, domestic manufacturing: IndustryIndia's furniture sector is set for a major boost. New free trade agreements will open up export markets and encourage investment. Domestic...
- Charting 6G Road Map: Talks soon with focus on desi tech and patentsIndia is initiating plans for a 6G mobile communication transition. Discussions will focus on developing local technology and fostering res...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- Desi chip companies fear MNCs will dip into their DLI 2.0 treatIndia is planning the second phase of its semiconductor incentive scheme, DLI 2.0. Concerns are rising among domestic startups that allowin...
- Stocks in news: SBI, Titan, Hyundai, BSE, Torrent Pharma, Axis BankIndian markets saw volatile trading on Thursday, closing nearly unchanged despite positive signals. Several companies including SBI, Titan,...
- India won't have to rely on foreign suppliers for new-gen refrigerant gases, says SRF's Ashish Bharat RamThe new refrigerants called hydrofluoroolefins, or HFOs, are quickly replacing older hydrofluorocarbons, or HFCs, in the USA and Europe as ...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Shots fired in the AI war: US and China clash over code and controlThe US-China AI rivalry has intensified, moving beyond innovation to a battle for talent, IP, and strategic tech. China's blocking of Meta'...
- After tariff wars, Trump is opening a new front in US-China rivalryThe US accuses China of stealing AI intellectual property, escalating the tech rivalry beyond tariffs. This move, potentially impacting chi...
- Tata Group firm Tejas Networks shares sink 6% after Q4 loss widens by 193%. Check detailsTejas Networks reported a significant widening of its net loss to Rs 211.3 crore in Q4 FY26, with revenue plummeting 82.6% year-on-year. De...
- Patent application filings in India rise 30.2% to 1.43 lakh in 2025-26: GoyalIndia's patent filings reached a historic high of over 1.43 lakh in FY 2025-26, a 30.2% jump. Domestic innovators led this surge, with Tami...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Syngene MDThe recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...
- Indian patenting system needs to improve, says WIPO chiefIndian patenting system needs to be improved for faster approvals, N N Prasad, Executive Director, WIPO, said here today.
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.
- Pfizer, Novartis and Merck test negative in IndiaPharma giants like Pfizer, Novartis and Merck have seen their market capitalisation erode over the last three years, as sales started to wi...
- Local pharma hits patent wall, new drug launches slideThis one’s a pop out for pharma. Revenues from new product launches in the pharma sector fell 48% to Rs 224.2 crore in ’05.
Load More
